ShockWave Medical, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $12.6 Billion | 6/14 | SYK $147.0B |
EW $44.7B |
DXCM $32.8B |
PODD $19.6B |
ALGN $15.3B |
SWAV $12.6B |
PEN $10.2B |
MASI $9.6B |
INSP $5.6B |
NARI $4.7B |
TMDX $2.3B |
TNDM $2.2B |
CLPT $497.4M |
OM $41.9M |
Gross Margin | 87% | 2/14 | PODD 100% |
SWAV 87% |
NARI 87% |
INSP 84% |
EW 81% |
ALGN 69% |
PEN 67% |
SYK 65% |
DXCM 60% |
CLPT 60% |
TMDX 56% |
MASI 52% |
TNDM 34% |
OM 34% |
Profit Margin | 25% | 2/14 | EW 100% |
SWAV 25% |
PODD 21% |
DXCM 14% |
ALGN 12% |
PEN 10% |
INSP 9% |
SYK 8% |
TMDX 4% |
MASI 2% |
TNDM -6% |
NARI -12% |
CLPT -61% |
OM -97% |
EBITDA margin | 19% | 3/14 | EW 30% |
PODD 24% |
SWAV 19% |
DXCM 15% |
PEN 15% |
ALGN 10% |
SYK 9% |
TMDX 8% |
INSP 7% |
NARI -5% |
TNDM -7% |
MASI -12% |
CLPT -64% |
OM -212% |
Quarterly Revenue | $218.8 Million | 9/14 | SYK $6.4B |
EW $1.4B |
DXCM $994.2M |
ALGN $977.9M |
MASI $504.6M |
PODD $372.6M |
TNDM $363.3M |
PEN $301.0M |
SWAV $218.8M |
INSP $203.2M |
NARI $153.4M |
TMDX $108.8M |
OM $28.7M |
CLPT $8.1M |
Quarterly Earnings | $55.3 Million | 6/14 | EW $3.1B |
SYK $546.0M |
DXCM $134.6M |
ALGN $116.0M |
PODD $77.5M |
SWAV $55.3M |
PEN $29.5M |
INSP $18.5M |
MASI $9.8M |
TMDX $4.2M |
CLPT -$5.0M |
NARI -$18.4M |
TNDM -$23.3M |
OM -$27.9M |
Quarterly Free Cash Flow | $27.5 Million | 8/14 | ALGN $326.5M |
EW $319.9M |
DXCM $88.3M |
PODD $76.1M |
PEN $51.0M |
INSP $44.3M |
MASI $33.0M |
SWAV $27.5M |
TNDM $21.5M |
NARI -$995,000 |
CLPT -$1.2M |
OM -$20.1M |
TMDX -$41.3M |
SYK -$0 |
Trailing 4 Quarters Revenue | $788.0 Million | 9/14 | SYK $22.6B |
EW $5.9B |
ALGN $4.0B |
DXCM $4.0B |
MASI $2.0B |
PODD $1.8B |
PEN $1.2B |
TNDM $973.7M |
SWAV $788.0M |
INSP $755.6M |
NARI $574.5M |
TMDX $401.1M |
OM $114.7M |
CLPT $30.4M |
Trailing 4 Quarters Earnings | $163.5 Million | 6/14 | SYK $6.4B |
EW $1.4B |
DXCM $994.2M |
ALGN $977.9M |
MASI $504.6M |
PODD $372.6M |
TNDM $363.3M |
PEN $301.0M |
SWAV $218.8M |
INSP $203.2M |
NARI $153.4M |
TMDX $108.8M |
OM $28.7M |
CLPT $8.1M |
Quarterly Earnings Growth | 41% | 6/14 | EW 698% |
INSP 317% |
PEN 220% |
TMDX 117% |
PODD 49% |
SWAV 41% |
OM 39% |
TNDM 29% |
DXCM 12% |
CLPT -3% |
ALGN -4% |
MASI -8% |
SYK -52% |
NARI -681% |
Annual Earnings Growth | -65% | 13/14 | EW 218% |
PODD 215% |
TMDX 215% |
INSP 174% |
DXCM 45% |
MASI 36% |
CLPT 30% |
OM 21% |
TNDM 10% |
ALGN -3% |
SYK -7% |
PEN -48% |
SWAV -65% |
NARI -934% |
Quarterly Revenue Growth | 36% | 4/14 | TNDM 96% |
TMDX 64% |
CLPT 41% |
SWAV 36% |
INSP 33% |
NARI 21% |
SYK 11% |
PEN 11% |
MASI 5% |
DXCM 2% |
ALGN 2% |
OM -6% |
EW -9% |
PODD -14% |
Annual Revenue Growth | 33% | 2/14 | TMDX 79% |
SWAV 33% |
CLPT 29% |
TNDM 26% |
INSP 25% |
NARI 19% |
PODD 12% |
MASI 11% |
DXCM 10% |
SYK 10% |
PEN 10% |
ALGN 0% |
EW -3% |
OM -17% |
Cash On Hand | $281.7 Million | 7/14 | EW $3.7B |
SYK $3.7B |
ALGN $1.0B |
PODD $902.6M |
DXCM $621.2M |
TMDX $330.1M |
SWAV $281.7M |
PEN $280.5M |
MASI $158.5M |
INSP $147.5M |
TNDM $49.0M |
NARI $41.1M |
OM $33.3M |
CLPT $21.6M |
Short Term Debt | $3.7 Million | 9/14 | SYK $12.2B |
ALGN $111.6M |
MASI $61.9M |
PODD $42.0M |
EW $24.2M |
DXCM $22.3M |
TNDM $18.0M |
PEN $14.5M |
SWAV $3.7M |
TMDX $2.5M |
OM $1.7M |
NARI $1.6M |
CLPT $536,000 |
INSP $109,000 |
Long Term Debt | $773.1 Million | 3/14 | DXCM $2.5B |
PODD $1.4B |
SWAV $773.1M |
MASI $733.2M |
EW $682.5M |
TMDX $508.5M |
TNDM $457.9M |
PEN $212.2M |
ALGN $96.4M |
NARI $31.1M |
INSP $25.2M |
CLPT $3.2M |
OM $3.2M |
SYK $0 |
PE | 76.87 | 4/14 | PEN 296.68 |
INSP 169.57 |
MASI 122.12 |
SWAV 76.87 |
TMDX 70.04 |
SYK 49.12 |
DXCM 48.12 |
PODD 46.59 |
ALGN 34.72 |
EW 10.75 |
TNDM -1.00 |
CLPT -1.00 |
NARI -1.00 |
OM -1.00 |
PS | 15.95 | 2/14 | CLPT 16.34 |
SWAV 15.95 |
PODD 10.82 |
PEN 8.81 |
DXCM 8.29 |
NARI 8.15 |
EW 7.61 |
INSP 7.42 |
SYK 6.51 |
TMDX 5.70 |
MASI 4.71 |
ALGN 3.87 |
TNDM 2.26 |
OM 0.37 |
PB | 16.72 | 3/14 | PODD 17.54 |
CLPT 17.15 |
SWAV 16.72 |
DXCM 16.55 |
TMDX 10.89 |
NARI 10.77 |
PEN 9.28 |
TNDM 9.27 |
INSP 8.05 |
MASI 6.57 |
EW 4.65 |
ALGN 3.89 |
SYK 3.42 |
OM 0.88 |
PC | 44.62 | 5/14 | NARI 113.76 |
MASI 60.64 |
DXCM 52.74 |
TNDM 44.92 |
SWAV 44.62 |
SYK 40.25 |
INSP 37.99 |
PEN 36.54 |
CLPT 23.05 |
PODD 21.72 |
ALGN 14.71 |
EW 12.16 |
TMDX 6.92 |
OM 1.26 |
Liabilities to Equity | 1.19 | 6/14 | OM 5.12 |
TNDM 3.03 |
TMDX 2.74 |
DXCM 2.21 |
PODD 1.71 |
SWAV 1.19 |
MASI 1.11 |
ALGN 0.61 |
NARI 0.60 |
CLPT 0.39 |
EW 0.35 |
PEN 0.34 |
INSP 0.14 |
SYK 0.00 |
ROA | 0.10 | 4/14 | EW 32% | PODD 14% | DXCM 11% | SWAV 10% | SYK 7% | ALGN 7% | INSP 4% | TMDX 4% | MASI 3% | PEN 2% | NARI -11% | TNDM -13% | CLPT -45% | OM -48% |
ROE | 0.22 | 4/14 | EW 44% |
PODD 38% |
DXCM 34% |
SWAV 22% |
TMDX 16% |
ALGN 11% |
SYK 7% |
MASI 5% |
INSP 5% |
PEN 3% |
NARI -18% |
TNDM -53% |
CLPT -63% |
OM -295% |
Current Ratio | 1.84 | 8/14 | INSP 7.99 |
PEN 3.95 |
EW 3.86 |
CLPT 3.59 |
NARI 2.66 |
ALGN 2.63 |
MASI 1.90 |
SWAV 1.84 |
PODD 1.59 |
DXCM 1.45 |
TMDX 1.36 |
TNDM 1.33 |
OM 1.20 |
SYK -1.00 |
Quick Ratio | 1.15 | 4/14 | PEN 296.68 |
INSP 169.57 |
MASI 122.12 |
SWAV 76.87 |
TMDX 70.04 |
SYK 49.12 |
DXCM 48.12 |
PODD 46.59 |
ALGN 34.72 |
EW 10.75 |
TNDM -1.00 |
CLPT -1.00 |
NARI -1.00 |
OM -1.00 |
Long Term Debt to Equity | 1.03 | 5/14 | TMDX} 2.42 |
TNDM} 1.93 |
DXCM} 1.27 |
PODD} 1.21 |
SWAV} 1.03 |
MASI} 0.50 |
PEN} 0.19 |
CLPT} 0.11 |
EW} 0.07 |
NARI} 0.07 |
OM} 0.07 |
INSP} 0.04 |
ALGN} 0.02 |
SYK} 0.00 |
Debt to Equity | 1.03 | 5/14 | TMDX 2.42 |
TNDM 2.00 |
DXCM 1.28 |
PODD 1.25 |
SWAV 1.03 |
MASI 0.50 |
SYK 0.28 |
PEN 0.21 |
CLPT 0.13 |
OM 0.10 |
NARI 0.08 |
EW 0.07 |
INSP 0.04 |
ALGN 0.02 |
Burn Rate | -11.98 | 10/14 | TMDX 19.69 |
MASI 4.53 |
CLPT 4.12 |
NARI 2.06 |
SYK 1.46 |
OM 1.17 |
TNDM 1.06 |
EW -1.21 |
INSP -8.45 |
SWAV -11.98 |
ALGN -12.37 |
PEN -16.10 |
DXCM -21.72 |
PODD -70.80 |
Cash to Cap | 0.02 | 9/14 | OM 0.79 |
TMDX 0.14 |
EW 0.08 |
ALGN 0.07 |
PODD 0.05 |
CLPT 0.04 |
PEN 0.03 |
INSP 0.03 |
SWAV 0.02 |
TNDM 0.02 |
DXCM 0.02 |
SYK 0.02 |
MASI 0.02 |
NARI 0.01 |
CCR | 0.50 | 8/14 | MASI 3.37 |
ALGN 2.82 |
INSP 2.39 |
PEN 1.73 |
PODD 0.98 |
OM 0.72 |
DXCM 0.66 |
SWAV 0.50 |
CLPT 0.24 |
EW 0.10 |
NARI 0.05 |
TNDM -0.93 |
TMDX -9.81 |
SYK |
EV to EBITDA | 308.03 | 2/14 | INSP} 382.86 |
SWAV} 308.03 |
TMDX} 289.17 |
SYK} 267.72 |
PEN} 230.35 |
PODD} 228.20 |
DXCM} 228.10 |
ALGN} 150.23 |
EW} 103.65 |
OM} -0.22 |
CLPT} -92.71 |
TNDM} -100.78 |
MASI} -170.90 |
NARI} -647.99 |
EV to Revenue | 16.58 | 1/14 | SWAV 16.58 |
CLPT 15.76 |
PODD 11.09 |
DXCM 8.77 |
PEN 8.76 |
NARI 8.13 |
INSP 7.25 |
EW 7.11 |
SYK 6.88 |
TMDX 6.14 |
MASI 4.99 |
ALGN 3.63 |
TNDM 2.70 |
OM 0.12 |